QualityStocksNewsBreaks Archives - Page 315 of 1424

MondayFeb 06, 2023 3:43 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight in Vegas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced that its Robot Roadshow will land at Silverton Hotel & Casino in Las Vegas, Nevada, from 10:00 a.m. to 2:00 p.m. PT on Feb. 7-9, 2023. The engaging experiential event is designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Las Vegas Roadshow landing will be guided by Knightscope experts, and visitors will be able to interact directly with each of the ASRs and see the Knightscope Security Operations Center (‘KSOC’) user interface in action.…

MondayFeb 06, 2023 3:08 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Grants RSUs as Part of Long-Term Incentive Plan

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently announced that it has granted an aggregate of 300,000 restricted share units (the “RSUs”) to its senior officers pursuant to its long-term incentive plan. The company’s plan is designed to compensate and reward its directors, officers, consultants and employees for working towards Eloro’s long-term objectives in alignment with the shareholders’ best interests. All granted RSUs have performance-related milestones in connection with the advancement of the company’s Iska Iska silver-tin polymetallic project in…

MondayFeb 06, 2023 2:00 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Animal Study Results Featured in Aegis Capital Corp. Updated Price Target

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is the subject of an updated report released from Aegis Capital Corp. The update reflects the strong results from BVXV’s latest animal study indicating that anti-COVID-19 NanoAb can prevent infection. According to the report, BiondVax reported that in a continuation of the study, COVID-19 illness was virtually prevented in hamsters that received BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2. The report noted that data gathered from the preclinical trial show that BiondVax’s…

MondayFeb 06, 2023 12:26 pm

QualityStocksNewsBreaks – Coyuchi Inc. Driving Growth While Focusing on Positive Environmental, Social Impacts

Coyuchi, the first organic luxury home goods brand for sustainable living, in August 2022 announced its first public offering under Regulation A+ authorization. “This round of funding will be used to grow Coyuchi’s leadership through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers and online marketplaces. The company has now exceeded $1 million in capital raising with the unique investment opportunity handled by Manhattan Street Capital. Funds raised during the beginning of the Regulation A+ offering have allowed Coyuchi to open a second retail location in the Palo Alto Town & Country Village… During…

MondayFeb 06, 2023 10:42 am

QualityStocksNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Wins Largest Commercial Lidar Deployment Contract in Tolling Sector to Date

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been awarded a multimillion sales contract from one of the leading U.S. highway tolling systems in the country. The company announced that its exclusive, state-of-the-art lidar solution will be deployed nationwide; the contract is designed to improve and enable accurate and intelligent tolling applications. According to the announcement, the large-scale contract calls for CPTN’s Sora series lidar sensors to be positioned on several major tollways located in the Tri-State area and Northern California in what is projected to be the largest commercial lidar deployment in the tolling…

FridayFeb 03, 2023 1:26 pm

QualityStocksNewsBreaks – CubCrafters Inc.’s Long Relationship with US Government Demonstrates Its Exceptional Abilities in Backcountry Aviation

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “For close to two decades now, CubCrafters has supplied aircraft to various U.S. Federal Government agencies, including the U.S. Air Force Research Laboratory, the U.S. Air Force Flight Academy, the U.S. Department of Agriculture (‘USDA’), the U.S. Department of Homeland Security (‘DHS’), and the U.S. Department of the Interior (‘DOI’)… The consistent appeal of CubCrafters’ aircraft stems from the fact that they have significantly lower operational costs compared to helicopters and other more expensive fixed-wing aircraft… In addition to the lower operational cost, CubCrafters…

FridayFeb 03, 2023 1:03 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Helping Companies to Affordably Transition from Dependence on Carbon Fuel

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, foresees exciting new opportunities available thanks to the government’s emphasis on driving the country toward a future free of its dependence on carbon fuel and otherwise inefficient utilities. “Correlate is focused on helping companies that develop and rent out commercial building properties succeed at acquiring solar, cogeneration, energy storage, and electric vehicle infrastructure, and doing so in a way that is both affordable and profit-improving for the client,” a recent article reads. “The company’s subsidiaries work harmoniously to analyze clients’ utilities performance. Correlate then provides recommendations for improvements based…

FridayFeb 03, 2023 12:33 pm

QualityStocksNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack, and HeartBeam AIMIGo(TM), the first and only credit-card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system to facilitate remote heart-attack detection… The company anticipates receiving regulatory approval soon for the use of the HeartBeam…

FridayFeb 03, 2023 12:00 pm

QualityStocksNewsBreaks – Why McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Is ‘One to Watch’

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. In addition, the company has a large exposure to copper through its subsidiary McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 9th largest undeveloped copper resource in the world. “McEwen Mining is a 68% shareholder in McEwen Copper, holder of a 100% interest in the Los Azules copper project in San Juan, Argentina… Its current copper resources are estimated at 10.2 billion pounds at a grade of 0.48% Cu (Indicated category) and an additional 19.3…

FridayFeb 03, 2023 11:50 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported that 67 patients have enrolled in the potentially pivotal phase 2 globally cited clinical study comparing drug candidate Berubicin’s effectiveness to second-line standard-of-care chemotherapy drug Lomustine. “The company plans to have more than 200 patients participate in the clinical trial on a 2:1 randomization schema between those receiving Berubicin and those receiving Lomustine… Berubicin’s performance in an initial safety trial conducted by another company in 2006 resulted in apparent life extension for some patients and complete remission for one patient who, unusually, survives nearly 17 years later. The ongoing study now seeks to demonstrate…

Site Search

Company Search

Category: QualityStocksNewsBreaks